ArticleMicrosystems & nanoengineering2026
Multilayered microelectrode array for monitoring electrophysiological signals of 3d neural networks in cerebral organoid.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Microelectrode arrays (MEAs) are widely used platforms for monitoring neuronal activity in biological systems. The advent of brain organoid technology-three-dimensional (3D) neural tissue models derived from human stem cells-has opened unprecedented opportunities to study network connectivity and developmental processes of brain-like tissues in vitro. However, most commercial MEAs are restricted to planar, two-dimensional configurations, limiting recordings to a single surface and failing to capture the multilayered architecture of organoids. To overcome this limitation, we develop a multilayered MEA (MLMEA) capable of interfacing with multiple depths within brain organoids. The MLMEA features customizable interlayer spacing achieved through the stacking of mesh-type electrode layers separated by mechanically compliant PDMS spacers. This design allows simultaneous, spatially resolved electrophysiological recordings across layers along the vertical axis, enabling detailed characterization of interlayer connectivity and network dynamics. Noninvasive integration of the MLMEA with cerebral organoid sustained for over four weeks demonstrates the stable, increasing neural activities with layer-specific electrophysiological metrics. Our findings demonstrate that MLMEA can reliably capture heterogeneous, depth-dependent neuronal activity, establishing it as a powerful tool for advancing 3D organoid-based neuroscience research and high-content drug screening.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.